Transgene SA TRGNF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.11M | -9.17M | -10.61M | -10.66M | -10.95M |
| Total Depreciation and Amortization | 394.30K | 396.60K | 384.20K | 385.80K | 377.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -481.50K | -484.40K | 949.90K | 954.00K | 1.20M |
| Change in Net Operating Assets | -2.17M | -2.19M | -1.84M | -1.85M | -812.60K |
| Cash from Operations | -11.37M | -11.44M | -11.12M | -11.17M | -10.18M |
| Capital Expenditure | -371.00K | -373.20K | -327.70K | -329.10K | -158.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.34M | 10.40M | -61.00M | -61.26M | -178.20K |
| Cash from Investing | 9.97M | 10.03M | -61.32M | -61.59M | -336.50K |
| Total Debt Issued | -- | -- | -10.15M | -10.15M | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -8.50K |
| Issuance of Common Stock | -- | -- | 52.56M | 52.56M | -- |
| Repurchase of Common Stock | -6.00K | -6.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.50K | -2.50K | 14.92M | 14.92M | 10.03M |
| Cash from Financing | -9.90K | -9.90K | 66.73M | 67.02M | 11.37M |
| Foreign Exchange rate Adjustments | 15.70K | 15.80K | -180.40K | -181.20K | -795.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 600.00 | 600.00 | -600.00 |
| Net Change in Cash | -1.40M | -1.41M | -5.89M | -5.91M | 57.90K |